ATE77548T1 - Xanthangummienthaltende arzneimittelformulierung mit verzoegerter freisetzung. - Google Patents

Xanthangummienthaltende arzneimittelformulierung mit verzoegerter freisetzung.

Info

Publication number
ATE77548T1
ATE77548T1 AT87300035T AT87300035T ATE77548T1 AT E77548 T1 ATE77548 T1 AT E77548T1 AT 87300035 T AT87300035 T AT 87300035T AT 87300035 T AT87300035 T AT 87300035T AT E77548 T1 ATE77548 T1 AT E77548T1
Authority
AT
Austria
Prior art keywords
xanthan gum
delayed release
gum containing
medicinal formulation
release medicinal
Prior art date
Application number
AT87300035T
Other languages
English (en)
Inventor
Mahendra Govind Pankhania
Colin David Melia
John Francis Lampard
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Application granted granted Critical
Publication of ATE77548T1 publication Critical patent/ATE77548T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT87300035T 1986-01-18 1987-01-06 Xanthangummienthaltende arzneimittelformulierung mit verzoegerter freisetzung. ATE77548T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868601204A GB8601204D0 (en) 1986-01-18 1986-01-18 Therapeutic agents
EP87300035A EP0234670B1 (de) 1986-01-18 1987-01-06 Xanthangummienthaltende Arzneimittelformulierung mit verzögerter Freisetzung

Publications (1)

Publication Number Publication Date
ATE77548T1 true ATE77548T1 (de) 1992-07-15

Family

ID=10591589

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87300035T ATE77548T1 (de) 1986-01-18 1987-01-06 Xanthangummienthaltende arzneimittelformulierung mit verzoegerter freisetzung.

Country Status (23)

Country Link
US (1) US5415871A (de)
EP (1) EP0234670B1 (de)
JP (1) JPH0669965B2 (de)
KR (1) KR940011242B1 (de)
AT (1) ATE77548T1 (de)
AU (2) AU608208B2 (de)
CA (1) CA1313133C (de)
DE (1) DE3779933T2 (de)
DK (1) DK175215B1 (de)
ES (1) ES2042541T4 (de)
FI (1) FI93608C (de)
GB (1) GB8601204D0 (de)
GR (1) GR3005796T3 (de)
IE (1) IE59333B1 (de)
IL (1) IL81281A (de)
IN (1) IN164250B (de)
MX (1) MX4949A (de)
MY (1) MY100721A (de)
NO (1) NO173317C (de)
NZ (1) NZ218907A (de)
PH (1) PH26408A (de)
PT (1) PT84133B (de)
ZA (1) ZA87173B (de)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1191674B (it) * 1986-03-07 1988-03-23 Eurand Spa Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
IT1250483B (it) * 1990-08-30 1995-04-07 Eurand Int Sistema di ritardo a matrice multipla
DE4140179C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Ibuprofen enthaltendes Arzneimittel
DE4140192C2 (de) * 1991-12-05 1996-02-29 Alfatec Pharma Gmbh Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140172C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Ibuprofen enthaltendes Arzneimittel
DE4140184C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Flurbiprofen enthaltendes Arzneimittel
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5292534A (en) * 1992-03-25 1994-03-08 Valentine Enterprises, Inc. Sustained release composition and method utilizing xanthan gum and an active ingredient
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
WO1994015643A1 (en) * 1992-12-30 1994-07-21 Fmc Corporation Readily available konjac glucomannan sustained release excipient
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5662933A (en) 1993-09-09 1997-09-02 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5464067A (en) * 1994-01-11 1995-11-07 Dulak; Joseph O. Golf marker cleaner and grass remover
US6395303B1 (en) * 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
FR2729857B1 (fr) 1995-01-27 1997-04-04 Rhone Poulenc Chimie Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire
WO1997026865A1 (en) * 1996-01-29 1997-07-31 Edward Mendell Co., Inc. Sustained release excipient
KR100321489B1 (ko) * 1996-07-08 2002-10-09 에드워드 멘델 컴파니 인코포레이티드 고용량의불용성약물용서방성매트릭스
IN186245B (de) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6607751B1 (en) * 1997-10-10 2003-08-19 Intellipharamaceutics Corp. Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US20030153623A1 (en) * 1998-07-22 2003-08-14 Yamanouchi Pharmaceutical Co., Ltd. Solid preparation containing sparingly soluble NSAIDs
GB9816723D0 (en) * 1998-08-01 1998-09-30 Boots Co Plc Therapeutic agents
WO2000033818A1 (en) 1998-12-11 2000-06-15 Nostrum Pharmaceuticals, Inc. Sustained release tablet containing hydrocolloid and cellulose ether
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
IL143375A0 (en) * 1999-09-30 2002-04-21 Penwest Pharmaceuticals Co Sustained release matrix systems for highly soluble drugs
US7235258B1 (en) * 1999-10-19 2007-06-26 Nps Pharmaceuticals, Inc. Sustained-release formulations for treating CNS-mediated disorders
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
WO2002015702A1 (en) * 2000-08-22 2002-02-28 Agresearch Limited A thermo-stable bio-matrix
WO2002015703A1 (en) * 2000-08-22 2002-02-28 Agresearch Limited A release composition and method of preparation
EP1330236A2 (de) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Amoxicillinhaltige arzneizusammensetzungen
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
AU2001227030A1 (en) * 2000-11-22 2002-06-03 Lupin Laboratories Limited Pharmaceutical composition for controlled release of an active ingredient
US20030072731A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US8329216B2 (en) * 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
BR0205721A (pt) * 2001-07-06 2003-09-30 Endo Pharmaceuticals Inc Formulações de oximorfona de liberação controlada
US6705028B2 (en) * 2001-09-12 2004-03-16 Honda Giken Kogyo Kabushiki Kaisha Self-propelled snowplow vehicle
US20030091635A1 (en) * 2001-09-26 2003-05-15 Baichwal Anand R. Opioid formulations having reduced potential for abuse
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US8192755B2 (en) 2001-11-19 2012-06-05 Lupin Limited Pharmaceutical composition for controlled release of a beta-lactam antibiotic
RU2336864C2 (ru) * 2002-03-22 2008-10-27 Цилаг Аг Лекарственные формы трамадола замедленного высвобождения
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US20060147527A1 (en) * 2002-12-13 2006-07-06 Cilag Ag Controlled release preparations comprising tramadol and topiramate
WO2004058152A2 (en) * 2002-12-16 2004-07-15 Ranbaxy Pharmaceuticals Inc. An extended release pharmaceutical composition of phenytoin sodium
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
US8802139B2 (en) * 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
JP2007528857A (ja) * 2003-07-11 2007-10-18 ミリアド ジェネティクス， インコーポレイテッド アルツハイマー病の処置のための薬学的方法、投与レジメンおよび投薬形態
EP1510205B1 (de) * 2003-09-01 2008-03-26 JPM - The Jordanian Pharmaceutical Manufacturing Co. Ltd. Universelle Zusammensetzung zur kontrollierten Wirkstofffreigabe enthaltend Xanthangummi und Natriumalginat
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
ES2244324B1 (es) * 2004-03-25 2006-11-16 Ferrer Internacional, S.A. Composiciones diureticas de liberacion prolongada.
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
MXPA06012165A (es) * 2004-04-29 2007-01-17 Keystone Retaining Wall System Chapas para muros, muros de contencion y similares.
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
WO2006020853A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
EP2404605B1 (de) 2004-08-25 2015-04-22 Essentialis, Inc. Pharmazeutische Formulierungen von Kalium-ATP-Kanalöffnern und deren Verwendungen
US20070077297A1 (en) 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
WO2006046954A1 (en) * 2004-10-26 2006-05-04 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
WO2006123357A2 (en) * 2005-02-22 2006-11-23 Sun Pharmaceutical Industries Limited Oral controlled release composition containing levetiracetam
US9757384B2 (en) 2005-04-06 2017-09-12 Essentialis, Inc. Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
KR20080039876A (ko) * 2005-07-22 2008-05-07 미리어드 제네틱스, 인크. 높은 약물 충진 제형 및 투여형
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
WO2007069874A1 (en) * 2005-12-16 2007-06-21 Hanmi Pharm. Co., Ltd. Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
EP2404604B1 (de) 2006-01-05 2019-02-06 Essentialis, Inc. Salze von Kalium-ATP-Kanalöffnern und deren Verwendungen
US8309104B2 (en) 2006-03-02 2012-11-13 Watson Pharmaceuticals, Inc. Oral controlled release formulation for sedative and hypnotic agents
US20070212414A1 (en) * 2006-03-08 2007-09-13 Penwest Pharmaceuticals Co. Ethanol-resistant sustained release formulations
CA2648280C (en) * 2006-04-03 2014-03-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US20080033045A1 (en) * 2006-07-07 2008-02-07 Myriad Genetics, Incorporated Treatment of psychiatric disorders
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
US20080318993A1 (en) * 2007-06-21 2008-12-25 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic Impairment
US20080318994A1 (en) 2007-06-21 2008-12-25 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
US20090124650A1 (en) * 2007-06-21 2009-05-14 Endo Pharmaceuticals, Inc. Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol
WO2009006483A1 (en) * 2007-07-02 2009-01-08 Essentialis, Inc. Salts of potassium atp channel openers and uses thereof
DE102007032662A1 (de) * 2007-07-13 2009-01-22 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen enthaltend ein oder mehrere Apiogalacturonane oder einen oder mehrere Apiogalacturonane enthaltenden Extrakt aus Zostera marina und einen zusätzlichen Gehalt an einem oder mehreren Hydrokolloiden
WO2011102506A1 (ja) * 2010-02-22 2011-08-25 第一三共株式会社 経口用徐放性固形製剤
EP2793853B1 (de) * 2011-12-23 2015-12-16 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmazeutische formulierungen aus flurbiprofen und glucosamin
US20150004229A1 (en) 2011-12-27 2015-01-01 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Combined pharmaceutical formulation containing diacerein
EP2819675A4 (de) 2012-02-27 2015-07-22 Essentialis Inc Salze von kalium-atp-kanalöffnern und verwendungen davon
WO2014007777A1 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Combined capsule formulations of nsaids
WO2014007778A1 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi COMBINED IMMEDIATE RELEASE FORMULATIONS OF NSAIDs
AU2015346196B2 (en) 2014-11-14 2019-01-31 Essentialis, Inc. Methods for treating subjects with prader-willi syndrome or smith-magenis syndrome
CN108904451A (zh) * 2018-07-27 2018-11-30 广州柏赛罗药业有限公司 缓释制剂

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR901111A (fr) * 1943-08-31 1945-07-18 Perfectionnement aux dispositifs de réglage de terrage des charruesbascules
US3065143A (en) 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
FR2138492A1 (en) * 1971-05-27 1973-01-05 Cerm Cent Europ Rech Mauvernay Basic aluminium salts of gum xanthane - pharmaceutical gelling agents
DE2130545A1 (de) 1971-06-19 1972-12-21 Merck Patent Gmbh Pharmazeutischer Formkoerper
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
JPS5470420A (en) * 1977-11-10 1979-06-06 Sanei Kagaku Kogyo Kk Binder for medical tablet
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
IN151913B (de) * 1980-01-11 1983-09-03 Boots Co Ltd
CA1207231A (en) * 1982-08-24 1986-07-08 Hans W. Zulliger Medicated suppository
US4717713A (en) * 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
JPS60219238A (ja) * 1984-04-14 1985-11-01 Hayashibara Biochem Lab Inc 徐崩性プルラン含有成形物とその製法
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8426152D0 (en) * 1984-10-16 1984-11-21 Reckitt & Colmann Prod Ltd Medicinal compositions
DE3440288A1 (de) * 1984-11-05 1986-05-07 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische zubereitung mit einem gehalt an mindestens einer schleimhautreizenden substanz oder dergleichen, insbesondere profen, sowie verfahren zu ihrer herstellung
BE901111A (fr) * 1984-11-22 1985-03-15 Benfar Representee Par Vanderl Composition pharmaceutiques a liberation prolongee, leur procede de preparation et leur utilisation.
EP0182772A3 (de) * 1984-11-22 1987-04-01 Benfar Arzneimittel mit verlängerter Freigabe, Verfahren zu deren Herstellung sowie deren Verwendung
JPS61130239A (ja) * 1984-11-30 1986-06-18 Dai Ichi Seiyaku Co Ltd 複合体
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
IT1191674B (it) * 1986-03-07 1988-03-23 Eurand Spa Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient

Also Published As

Publication number Publication date
ZA87173B (en) 1987-08-26
DE3779933T2 (de) 1992-12-10
DE3779933D1 (de) 1992-07-30
DK14887A (da) 1987-07-19
NO173317C (no) 1993-12-01
IE863420L (en) 1987-07-18
EP0234670B1 (de) 1992-06-24
ES2042541T4 (es) 1996-07-16
NO870181L (no) 1987-07-20
PT84133A (en) 1987-02-01
GR3005796T3 (de) 1993-06-07
EP0234670A3 (en) 1988-01-13
PH26408A (en) 1992-07-02
JPS62181227A (ja) 1987-08-08
AU628754B2 (en) 1992-09-17
NO870181D0 (no) 1987-01-16
FI870155A (fi) 1987-07-19
EP0234670A2 (de) 1987-09-02
FI93608C (fi) 1995-05-10
FI870155A0 (fi) 1987-01-15
AU6762587A (en) 1987-07-23
GB8601204D0 (en) 1986-02-19
JPH0669965B2 (ja) 1994-09-07
NZ218907A (en) 1989-05-29
CA1313133C (en) 1993-01-26
FI93608B (fi) 1995-01-31
IE59333B1 (en) 1994-02-09
MX4949A (es) 1993-12-01
KR940011242B1 (ko) 1994-12-03
MY100721A (en) 1991-01-31
DK175215B1 (da) 2004-07-12
AU7946291A (en) 1991-09-12
US5415871A (en) 1995-05-16
ES2042541T3 (es) 1993-12-16
NO173317B (no) 1993-08-23
IL81281A (en) 1990-11-29
DK14887D0 (da) 1987-01-13
PT84133B (pt) 1989-05-31
AU608208B2 (en) 1991-03-28
IN164250B (de) 1989-02-04
IL81281A0 (en) 1987-08-31
KR870006896A (ko) 1987-08-13

Similar Documents

Publication Publication Date Title
ATE77548T1 (de) Xanthangummienthaltende arzneimittelformulierung mit verzoegerter freisetzung.
IN169330B (de)
DE69329781T2 (de) Konzentrierte, bioverfügbare kalziumquelle
CA2063819A1 (en) Chewing gum composition with accelerated, controlled release of active agents
MY101784A (en) Novel pharmacological compounds
PT615754E (pt) Formas solidas de administracao oral de libertacao controlada flupertina
DE69325236D1 (de) Pharmazeutische Zusammensetzungen enthaltend Urodeoxycholicsäure
GR3002835T3 (en) Pharmaceutical compositions containing pentamidine
SE8703889D0 (sv) Sustained release pharmaceutical compositions
PH27567A (en) Topical compositions
SE8704240D0 (sv) Analgesic preparations
JPS57142913A (en) Donor of physiologically active substance
NO894083L (no) Farmasoeytiske blandinger for behandling av adrenoleukodystrophy.
ES2033512T3 (es) Composicion antiastenica, su procedimiento de preparacion y su utilizacion.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee